Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
Journal of the American Heart Association
|
November 15, 2024
Baseline Characteristics of Participants in STAREE: A Randomized Trial for Primary Prevention of Cardiovascular Disease Events and Prolongation of Disability-Free Survival in Older People
Sophia Zoungas, Chris Moran, Andrea J Curtis, et al.
JAMA Network Open
|
April 20, 2026
Cognitive Decline Preceding Incident Cardiovascular Events in Older Adults
Swarna Vishwanath, Zimu Wu, Andrew Tonkin, et al.
Alzheimer'S Research & Therapy
|
May 18, 2024
The impact of incident stroke on cognitive trajectories in later life
Swarna Vishwanath, Ingrid Hopper, Geoffrey C Cloud, et al.
Frontiers in Neurology
|
March 15, 2021
COVID-19 Pandemic Impact on Care for Stroke in Australia: Emerging Evidence From the Australian Stroke Clinical Registry
Dominique A Cadilhac, Joosup Kim, Emma K Tod, et al.
Kidney International
|
September 13, 2020
Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney disease
Rory Wolfe, James B Wetmore, Robyn L Woods, et al.
The Medical Journal of Australia
|
July 11, 2024
National Hypertension Taskforce of Australia: a roadmap to achieve 70% blood pressure control in Australia by 2030
Aletta E Schutte, Belinda Bennett, Clara K Chow, et al.
Healthcare (Basel, Switzerland)
|
December 8, 2023
A Network of Sites and Upskilled Therapists to Deliver Best-Practice Stroke Rehabilitation of the Arm: Protocol for a Knowledge Translation Study
Leeanne M Carey, Liana S Cahill, Jannette M Blennerhassett, et al.
The Lancet. Neurology
|
May 7, 2022
Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trial
Andrew Bivard, Henry Zhao, Leonid Churilov, et al.
European Heart Journal
|
August 12, 2025
Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial
Rory Wolfe, Jonathan C Broder, Zhen Zhou, et al.
The Lancet. Neurology
|
October 31, 2020
Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial
Atte Meretoja, Nawaf Yassi, Teddy Y Wu, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
Journal of the American Heart Association
|
November 15, 2024
Baseline Characteristics of Participants in STAREE: A Randomized Trial for Primary Prevention of Cardiovascular Disease Events and Prolongation of Disability-Free Survival in Older People
Sophia Zoungas, Chris Moran, Andrea J Curtis, et al.
JAMA Network Open
|
April 20, 2026
Cognitive Decline Preceding Incident Cardiovascular Events in Older Adults
Swarna Vishwanath, Zimu Wu, Andrew Tonkin, et al.
Alzheimer'S Research & Therapy
|
May 18, 2024
The impact of incident stroke on cognitive trajectories in later life
Swarna Vishwanath, Ingrid Hopper, Geoffrey C Cloud, et al.
Frontiers in Neurology
|
March 15, 2021
COVID-19 Pandemic Impact on Care for Stroke in Australia: Emerging Evidence From the Australian Stroke Clinical Registry
Dominique A Cadilhac, Joosup Kim, Emma K Tod, et al.
Kidney International
|
September 13, 2020
Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney disease
Rory Wolfe, James B Wetmore, Robyn L Woods, et al.
The Medical Journal of Australia
|
July 11, 2024
National Hypertension Taskforce of Australia: a roadmap to achieve 70% blood pressure control in Australia by 2030
Aletta E Schutte, Belinda Bennett, Clara K Chow, et al.
Healthcare (Basel, Switzerland)
|
December 8, 2023
A Network of Sites and Upskilled Therapists to Deliver Best-Practice Stroke Rehabilitation of the Arm: Protocol for a Knowledge Translation Study
Leeanne M Carey, Liana S Cahill, Jannette M Blennerhassett, et al.
The Lancet. Neurology
|
May 7, 2022
Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trial
Andrew Bivard, Henry Zhao, Leonid Churilov, et al.
European Heart Journal
|
August 12, 2025
Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial
Rory Wolfe, Jonathan C Broder, Zhen Zhou, et al.
The Lancet. Neurology
|
October 31, 2020
Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial
Atte Meretoja, Nawaf Yassi, Teddy Y Wu, et al.
Page
of 6